P53 Regulation-Association Long Non-Coding RNA (LncRNA PRAL) Inhibits Cell Proliferation by Regulation of P53 in Human Lung Cancer
Author:
Affiliation:
1. Department of Surgery, Xi’an Red Cross Hospital, Affiliated to School of Medicine, Xi’an Jiao Tong University, Xi’an, Shanxi, China (mainland)
2. Maternal and Child Care Service Center of Changan District, Xi’an, Shanxi, China (mainland)
Publisher
International Scientific Information, Inc.
Subject
General Medicine
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Construction and validation of a novel disulfidptosis-related lncRNA signature for prognostic prediction in lung adenocarcinoma;2023-09-07
2. The lncRNA prostate androgen-regulated transcript 1 (PART-1) promotes non-small cell lung cancer progression by regulating the miR-204-3p/IGFBP-2 pathway;Journal of Laboratory Medicine;2023-02-01
3. Exploring the recent trends in perturbing the cellular signaling pathways in cancer by natural products;Frontiers in Pharmacology;2022-09-08
4. Curcumin against gastrointestinal cancer: A review of the pharmacological mechanisms underlying its antitumor activity;Frontiers in Pharmacology;2022-09-02
5. LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside;Cell Death Discovery;2022-08-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3